glp-1 and bariatric surgery vs. Surgery: 1- Weight Loss Surgery: 25-30% + TBWL for 10+ years GLP-1: 15-21% in trials, less in real-world 2- Metabolic Benefits: > GLP-1 3- Comorbidities: Greater resolution with GLP-1 Archives - Rocky Mountain

Transition plan to insulin / discontinuing GLP-1 RA

There is no insulin required

Products marketed as personalized blends with added vitamins or other ingredients, without a clear clinical rationale, are often designed to tout those additions to sidestep regulations rather than to benefit the patient

Like insulin, GLP-1 receptor agonists are biologic protein-based drugs, and improper storage can break down their molecular structure, making them less effective or even unsafe

The decision to continue or discontinue GLP-1 therapy should be made with your healthcare provider based on your individual risk factors, response to treatment, and long-term health goals

The therapeutic application of GLP-1 agonists for obesity is grounded in well-established physiological mechanisms that extend beyond glucose regulation to encompass appetite control and energy homeostasis